Search Results - "Barme, Greg"

Cross-Linked Hyaluronan Gel Reduces the Acute Rectal Toxicity of Radiotherapy for Prostate Cancer by Wilder, Richard B., M.D, Barme, Greg A., M.D, Gilbert, Ronald F., M.D, Holevas, Richard E., M.D, Kobashi, Luis I., M.D, Reed, Richard R., M.D, Solomon, Ronald S., M.D, Walter, Nancy L., R.N, Chittenden, Lucy, B.S, Mesa, Albert V., M.S, Agustin, Jeffrey, B.S, Lizarde, Jessica, B.S, Macedo, Jorge, Ravera, John, M.D, Tokita, Kenneth M., M.D

“…Purpose To prospectively analyze whether cross-linked hyaluronan gel reduces the mean rectal dose and acute rectal toxicity of radiotherapy for prostate…”
Get full text

Cross-linked hyaluronan gel improves the quality of life of prostate cancer patients undergoing radiotherapy by Wilder, Richard B, Barme, Greg A, Gilbert, Ronald F, Holevas, Richard E, Kobashi, Luis I, Reed, Richard R, Solomon, Ronald S, Walter, Nancy L, Chittenden, Lucy, Mesa, Albert V, Agustin, Jeffrey K, Lizarde, Jessica, Macedo, Jorge C, Ravera, John, Tokita, Kenneth M

“…Abstract Purpose To test the hypothesis that cross-linked hyaluronan gel (Hylaform) does not affect the quality of life (QOL) of prostate cancer patients…”
Get full text

Preliminary results in prostate cancer patients treated with high-dose-rate brachytherapy and intensity modulated radiation therapy (IMRT) vs. IMRT alone by Wilder, Richard B, Barme, Greg A, Gilbert, Ronald F, Holevas, Richard E, Kobashi, Luis I, Reed, Richard R, Solomon, Ronald S, Walter, Nancy L, Chittenden, Lucy, Mesa, Albert V, Agustin, Jeffrey K, Lizarde, Jessica, Macedo, Jorge C, Ravera, John, Tokita, Kenneth M

“…Abstract Purpose To analyze results with high-dose-rate (HDR) brachytherapy and intensity modulated radiation therapy (IMRT) vs. IMRT alone for prostate…”
Get full text

The Use of an Injectable Spacer Material in Conjunction With High Dose-Rate Brachytherapy for Prostate Cancer by Tokita, Kenneth M., MD, Chittenden, Lucy, BS, Mesa, Albert, MS, Lane, Jessica, Kibuishi, Emi, Harrison, Judith, MD, Gilbert, Ron, MD, Barme, Greg, MD, Kobashi, Luis, MD, Spitz, Aaron, MD, Ravera, John, MD

Get full text

Development and multicenter case-control validation of urinary comprehensive genomic profiling for urothelial carcinoma diagnosis, surveillance, and risk prediction by Salari, Keyan, Sundi, Debasish, Lee, Jason J, Wu, Shulin, Wu, Chin-Lee, DiFiore, Gabrielle, Yan, Q Robert, Pienkny, Andrew, Lee, Chi K, Oberlin, Daniel, Barme, Greg, Piser, Joel, Kahn, Robert, Collins, Edward, Phillips, Kevin G, Caruso, Vincent M, Goudarzi, Mahdi, Garcia-Ransom, Monica, Lentz, Peter S, Evans-Holm, Martha E, MacBride, Andrew R, Fischer, Daniel S, Haddadzadeh, Iden J, Mazzarella, Brian C, Gray, Joe W, Koppie, Theresa M, Bicocca, Vincent T, Levin, Trevor G, Lotan, Yair, Feldman, Adam S

“…Urinary comprehensive genomic profiling (uCGP) uses next-generation sequencing to identify mutations associated with urothelial carcinoma (UC) and has the…”
Get full text